New Tests Launched in November

By Emily Linginfelter • December 13, 2018

Share this:

In November 2018, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Test

New tests launched in November 2018 by Mayo Clinic Laboratories:

• • Cysticercosis Antibody, IgG, Serum (Mayo ID: CYSTS)
  • Toxocara Antibody, IgG, Serum (Mayo ID: TOXOC)
  • Rivaroxaban, Anti-Xa, Plasma (Mayo ID: RIVAR)
  • Apixaban, Anti-Xa, Plasma (Mayo ID: APIXA)
  • Epilepsy/Seizure Genetic Panels by Next-Generation Sequencing (NGS) (Mayo ID: ESPAN)

Test Updates

In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories:

• All New Tests
• Test Changes
• Test Status Updates
• View All Updates

Emily Linginfelter

Emily Linginfelter is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Emily has worked at Mayo Clinic since 2018.